Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

enVVeno Medical (NVNO) Net Income towards Common Stockholders (2017 - 2020)

enVVeno Medical has reported Net Income towards Common Stockholders over the past 4 years, most recently at -$5.0 million for Q4 2020.

  • For Q4 2020, Net Income towards Common Stockholders fell 116.41% year-over-year to -$5.0 million; the TTM value through Dec 2020 reached -$10.0 million, down 31.28%, while the annual FY2025 figure was -$20.2 million, 13.78% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2020 was -$5.0 million at enVVeno Medical, down from -$2.0 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at -$1.4 million in Q2 2017 and troughed at -$8.2 million in Q2 2018.
  • A 4-year average of -$2.7 million and a median of -$1.9 million in 2019 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 503.68% in 2018 and later soared 76.34% in 2019.
  • Year by year, Net Income towards Common Stockholders stood at -$3.3 million in 2017, then surged by 45.22% to -$1.8 million in 2018, then decreased by 28.58% to -$2.3 million in 2019, then tumbled by 116.41% to -$5.0 million in 2020.
  • Business Quant data shows Net Income towards Common Stockholders for NVNO at -$5.0 million in Q4 2020, -$2.0 million in Q3 2020, and -$1.5 million in Q2 2020.